Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 8 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Progenics Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/progenics-pharmaceuticals-inc
Overview
Progenics Pharmaceuticals, Inc. is an oncology company focused on the development of innovative medicines and artificial intelligence to find, fight and follow cancer. It is a subsidiary of Lantheus Holdings, Inc.
Therapeutic areas
FDA compliance signals
8 FDA enforcement records linked to this company.
- 4832020-03-20
Investigations of discrepancies, failures
- 4832020-03-20
Incoming material area
- 4832020-03-20
Aseptic Processing Area
- 4832020-03-20
Review of representative number of batches
- 4832020-03-20
Procedures for sterile drug products
- 4832020-03-20
Computer control of master formula records
- 4832020-03-20
Adequate space lacking to prevent mix-ups and contamination
- 4832020-03-20
Procedures not in writing, fully followed
Is this Progenics Pharmaceuticals, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.